Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4523402 Target Snapshot

Methylcytosine dioxygenase TET1 · SINGLE PROTEIN · Homo sapiens

84Compounds
28Assays
2Approved Drugs
116.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q8NFU7. Use UniProt Q8NFU7 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8NFU7 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Methylcytosine dioxygenase TET1 as ChEMBL target CHEMBL4523402, mapped to UniProt Q8NFU7. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Methylcytosine dioxygenase TET1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4523402
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q8NFU7
Methylcytosine dioxygenase TET1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Methylcytosine dioxygenase TET1 is the right protein anchor across sources, using UniProt Q8NFU7 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMethylcytosine dioxygenase TET1
UniProt AccessionQ8NFU7
Component TypeProtein
Sequence Length2136 aa

Methylcytosine dioxygenase TET1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Methylcytosine dioxygenase TET1, mapped to UniProt Q8NFU7. Sequence length is 2136 aa.

Mapped IDQ8NFU7
Review nameMethylcytosine dioxygenase TET1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
Assay Mix

Activity Type Distribution

IC5083.0
KI2.0
EC5031.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5527999 7.74 IC50 18.2 Preclinical
CHEMBL5557793 6.76 IC50 173.78 Preclinical
CHEMBL5559263 6.71 IC50 194.98 Preclinical
CHEMBL5549950 6.69 IC50 204.17 Preclinical
CHEMBL5532540 6.62 IC50 239.88 Preclinical
CHEMBL5565375 6.6 IC50 250.0 Preclinical
CHEMBL3785455 6.6 IC50 251.19 Preclinical
CHEMBL5557372 6.59 IC50 257.04 Preclinical
CHEMBL5557587 6.57 IC50 269.15 Preclinical
CHEMBL5561497 6.44 IC50 363.08 Preclinical
Distribution

pChEMBL Value Distribution

10
5.0
12
5.5
13
6.0
10
6.5
0
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

28
Total Assays
65
Tested Compounds
1
Assay Types
Binding — 28 assays, 65 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 17 63 5.5
single protein format 11 2 5.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine